U.S. Online Retail and Ecommerce Stock News

Wondering if ICF International is an overlooked bargain or a value trap? If you're curious about what the numbers say, you're in the right place. ICF International's shares have pulled back sharply, losing 8.5% over the past week and 14.3% in the past month. They are now down 31.6% year-to-date. Recently, ICF International announced the acquisition of a leading energy and utilities consulting firm. This sparked new conversations around its long-term strategy. Some investors see this move as...

Clorox (CLX) delivered standout results this year, posting 121.6% earnings growth that sharply reverses its five-year trend of -14.8% per year. The company’s net profit margin jumped to 11.7% from 4.8% last year, underlining a significant rise in profitability. While forecasts show earnings growing at 5.6% per year and revenue at 2.2% per year, both below the US market, investors will note the current 17x Price-to-Earnings ratio sits under peer and industry averages, and shares trade well...

Wingstop (WING) posted net profit margins of 25.5%, up from 17.1% last year, reflecting a notable boost in profitability. Earnings grew 73% over the past year, outpacing its five-year average growth of 39.1% per year. Forecasts point to ongoing, but more modest, annual EPS growth of 5.14% and revenue expanding at 15.8% per year, significantly ahead of the broader US market's 10.5%. Investors may be weighing these strong operational numbers and margin improvements against a share price of...

PLAYSTUDIOS (MYPS) saw its losses accelerate at an average rate of 56.9% per year over the last five years, and the company remains unprofitable, with forecasts calling for continued losses through the next three years. Revenue is also projected to decline by 2.1% annually, adding further pressure on profit margins. Despite these tough numbers, MYPS trades at $0.82, a notable discount to its estimated fair value of $3.40. Valuation metrics stand out versus peers in the sector. See our full...

UMH Properties (UMH) has seen its earnings forecast surge, with analysts projecting 58.2% annual earnings growth in the years ahead, outpacing the broader US market’s 16% pace. While revenue is expected to grow at 8.9% per year, which trails the sector average, the company has become profitable over the last five years, averaging 13.2% earnings growth annually. Despite a slip in net profit margins from 3.9% to 2.5% year-over-year, investors are likely to focus on UMH’s high-quality earnings...

Energys Group (ENGS) has reported continued losses, with net losses growing at an average annual rate of 14.1% over the past five years. The company's Price-to-Sales Ratio stands at 17.5x, which is significantly above the industry average of 1.4x and the peer group’s 4.8x. With no concrete signs of margin improvement or profit growth in the recent data, investors currently face a situation defined by persistently elevated valuation multiples and a lack of positive earnings momentum. See our...

Willis Lease Finance (WLFC) reported a net profit margin of 17.3%, just below last year's 18.2%, with recent earnings growth of 23.4% that trails its robust five-year annual average of 63.2%. Over the longer term, the company has demonstrated impressive earnings power and maintains high-quality results, even as projected 3.8% annual revenue growth lags the broader US market forecast of 10.5%. See our full analysis for Willis Lease Finance. Now, let's see how these numbers measure up against...

Superior Group of Companies (SGC) is forecasting earnings growth of 50% per year for the next three years, easily outpacing the expected 16% annual growth rate for the US market. Revenue is forecast to grow at 3.4% per year, which trails the US market’s 10.5% pace. The company’s net profit margin has slipped to 1% from last year’s 2.4%, after a five-year stretch of earnings declining by 29.1% per year. Despite the ongoing pressure on margins and a history of shrinking profits, investors are...

Cheesecake Factory (CAKE) boosted its net profit margin to 4.3% from last year’s 3.6%, marking a solid stretch of improvement since becoming profitable, with annualized earnings growth of 60.9% over five years. Last year’s earnings rose by 25.5%. However, that is now below the longer-term average, and revenue is forecast to grow at a slower 5.1% annually compared to the broader US market’s 10.5%. While the company’s P/E ratio of 14.8x looks attractive next to the sector average, the stock...

Uniti Group (UNIT) reported revenue growth forecasts of 18.9% per year, well above the US market’s 10.5% rate. Net profit margins soared to 98.1% from just 8.7% last year. EPS growth came in at a hefty 1,469% year-over-year, surpassing the five-year average of 74.8% and marking a clear swing to profitability over the period. Despite these eye-catching figures and a rock-bottom price-to-earnings ratio of just 0.9x (far below peers), future projections are less optimistic. The company is...

Black Stone Minerals (BSM) reported net profit margins of 57.1%, a drop from last year’s 75.3%, as annual earnings growth over the past five years hit 17.2%. Current forecasts project the company’s earnings will grow by 7.8% per year, with revenue set to rise 7.9% per year. Both figures are below the US market averages of 16% and 10.5%, respectively. Investors are likely weighing the robust margin level and appealing valuation against a modest outlook for forward growth and recent pressure on...

Exagen (XGN) is set to outpace the broader US market with revenue forecast to rise 11.7% per year, compared to the expected 10.5% market growth. Despite a persistent lack of profitability, the company has trimmed losses at an average annual rate of 4.7% over the past five years. The narrative is defined by rapid top-line expansion and shares trading at a 3.7x Price-to-Sales Ratio, which is below both the peer average of 6.5x and the sector’s 10.8x benchmark. The current share price of $10.77...

Viper Energy (VNOM) reported revenue growth forecasted at 19.65% per year, outpacing the US market’s expected 10.5% annual rate. However, net profit margins slipped to 21.4%, down from 26% last year. Recent annual earnings growth of 19% trails its impressive five-year average of 53.9%. Although earnings are still expected to grow, the anticipated 2% annual rate is set to lag behind the wider US market forecast of 16% per year. Analysts are weighing consistent revenue and earnings progress...

ADTRAN Holdings (ADTN) is currently unprofitable, having seen its losses grow at an average rate of 53.5% per year over the past five years. Despite the challenging bottom line, revenue is forecast to grow at 10.4% per year, just below the broader U.S. market’s 10.5% projection. Earnings are expected to increase a remarkable 123.4% per year and the company could become profitable within the next three years. Investors are likely to weigh the discounted share price and strong growth outlook...

Heron Therapeutics (HRTX) is forecast to deliver standout earnings momentum, with annual earnings growth of 60.89% expected and a projected move into profitability within the next three years. Over the past five years, the company remained in the red but steadily narrowed its losses, cutting them by an average of 39.8% per year. Revenue growth is forecast at 15.9% per year, outpacing the broader US market’s 10.5% yearly expectation. Heron’s Price-to-Sales Ratio of 1.3x points to better value...

Beam Therapeutics (BEAM) remains unprofitable, and the company’s losses have widened at a rate of 2.2% per year over the past five years. Meanwhile, revenue is forecast to climb at an annual rate of 53%, outpacing the broader US market's projected 10.5% revenue growth. With these growth expectations, investors are balancing the promise of rapid expansion against persistent operating losses, a share price that has been volatile over the past three months, and a notably high Price-to-Sales...

CPI Card Group (PMTS) posted net profit margins of 2.8%, down from 3.4% last year, highlighting a decline in profitability. The company’s earnings grew at an average annual rate of 1.3% over the past five years, though earnings growth turned negative this most recent year. While PMTS is forecasted to achieve an 8.3% compound annual growth rate in revenue, which is slower than the US market’s 10.5%, its Price-To-Earnings ratio of 11x stands well below peer and industry averages. With the share...

National Storage Affiliates Trust (NSA) posted a year shaped by slowing expansion, with earnings projected to grow at 6.68% per year and revenue at 3.3% per year. Both figures trail the US market, which averages 16% and 10.5%, respectively. After delivering 8.9% average annual earnings growth over the past five years, NSA saw its most recent year marked by negative earnings growth and a net profit margin slip from 18.2% to 6.4%. Investors are weighing consistent, if muted, long-term growth...

Chicago Atlantic Real Estate Finance (REFI) delivered impressive 11.8% annual earnings growth over the past five years, with high quality results supporting its profitability. Recent filings show net profit margins at 65.9%, just below last year's 67.8% mark. Guidance now signals a 2.8% yearly decline in earnings over the coming three years and revenue growth of 5.8% per year, which lags the US market’s 10.5% forecast. Investors face a key question as they weigh REFI’s discounted share price...

Ecovyst (ECVT) reported continued unprofitability, recording losses that have increased at an annual rate of 12.9% over the past five years. Despite these challenges, analysts forecast an 85.2% annual growth in earnings moving forward, with the company expected to reach profitability within three years. The share price trades well below the estimated fair value of $28.83, sitting at $7.84, while the Price-To-Sales ratio of 1.2x remains in line with the broader US chemicals industry. Investors...

Orthofix Medical (OFIX) remains unprofitable, with losses expanding at a steep 42.7% annual rate over the last five years. Despite revenue being forecast to grow at 4.8% per year, lagging the broader US market’s 10.5% pace, the share price sits at $14.87, which is well below an estimated fair value of $25.85. For investors, the premium lies in the stock’s discounted valuation, as Orthofix trades with a notably low 0.7x price-to-sales ratio compared to much higher industry and peer multiples,...

Douglas Elliman (DOUG) remains in the red this year, with losses compounding by an annualized 54.2% over the last five years and no turnaround in net profit margin. Its price-to-sales ratio sits at 0.2x, a significant discount to the 3.3x peer average and 2.6x industry mark. This places shares at the lower end of sector valuation. With revenue and earnings showing no signs of growth, investors face few immediate reasons for optimism beyond the company’s comparatively low sales multiple. See...

Brightstar Lottery (BRSL) remains in the red but is eyeing a turnaround, with losses shrinking by 51.4% per year over the past five years and expectations for profitability within the next three. While earnings are projected to surge by 76.68% per year, revenue is set to grow more modestly at 1.3% per year, trailing the 10.5% US market average. With margins still negative and profitability yet to be delivered, investors are weighing BRSL's rapid earnings forecast against its slow revenue...

Wondering if Barrett Business Services could be a hidden value play or just another stock on your watchlist? Let’s dig into what really matters when sizing up its worth. After climbing a solid 8.4% over the past year and delivering an impressive 139.1% return in the last five years, the stock has recently cooled off, sliding 2.7% in the past week and 10.4% this past month. Shares have drifted in recent weeks as sector momentum faded and investors weighed mixed signals from broader labor...